Patent · US Active

Combinations and uses thereof

US9289490B2 · kind B2 · utility

7Cited by

4References

20Claims

0Family size

Assignee

MORPHOSYS AG · DE

Inventors

Lisa Rojkjaer · Hedingen, CH
Rainer Boxhammer · Aying, DE
Jan Endell · Munich, DE
Mark Winderlich · Munich, DE
Christofer Samuelsson · Holzkirchen, DE

Key dates

Filing date	Sep 29, 2014
Grant date	Mar 22, 2016
Priority date	—
Expiry date	Sep 29, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure describes a pharmaceutical combination of an anti-CD38 antibody and lenalidomide and a pharmaceutical combination of an anti-CD38 antibody and bortezomib.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.